OPTN/SRTR 2020 Annual Data Report: Lung
Maryam Valapour, Carli J. Lehr, M.A. Skeans, Jodi M. Smith, E. Miller, R. Goff, T. Mupfudze, K. Gauntt, Jon J. Snyder
Abstract
For the first time in a decade, both the number of candidates added to the waiting list and the number of lung transplants performed decreased from the year prior; the number of lung donors also declined. This slowing of transplant activities in 2020 was associated with a modest increase in waitlist mortality. The year 2020 was notable for the global outbreak of the COVID-19 pandemic, which undoubtedly influenced all trends noted in lung transplantation. Time to transplant continued to decrease, with a median time to transplant of 1.4 months across all waitlist candidates. Posttransplant survival remained stable, with 89.4% of transplant recipients surviving to 1 year, 74.8% to 3 years, and 61.2% to 5 years.